Half of U.S. adults with diabetes say managing diabetes is more difficult during the holidays versus other times of the year
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 20 to 23, 2021. This …
mRNA COVID-19 Vaccine Less Protective in Elderly With Comorbidity
At ≥7 days after second dose, effectiveness of mRNA COVID-19 vaccine was 69 percent against infection, 86 percent against related death
Three Days of Remdesivir Cuts Risk for Severe COVID-19 in Outpatients
Three-day course of treatment results in reduced risk for hospitalization or death compared with placebo
2019 to 2020 Saw 16.8 Percent Increase in U.S. Death Rate
Age-specific death rates increased for each age group 15 years and older; COVID-19 became third leading cause of death in 2020
FDA Approves Pfizer Pill as First At-Home COVID-19 Treatment
Recent trial showed Paxlovid cut the odds for hospitalization and death by nearly 90 percent in high-risk people
U.S. Army Reports Progress on COVID-19 Vaccine That Fights All Variants
Animal studies have already shown new vaccine induces highly potent antibody responses against major variants
13 Million Adults Delaying or Skipping Meds Due to Costs
Drug unaffordability is an issue regardless of insurance status and across private, public payers
COVID-19 Certification Mandates May Increase Vaccine Uptake
Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates
Omicron Now Accounts for 73 Percent of New COVID-19 Cases
Rate suggests there were more than 650,000 omicron infections in the United States last week